Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Squamous Cell Carcinoma of the Head or Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00397904
What this trial is testing

Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center 16
Large-scale testing (Phase 3)Active Not RecruitingNCT04590963
What this trial is testing

Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
AstraZeneca 370
Early research (Phase 1)Study completedNCT02636036
What this trial is testing

Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors

Who this might be right for
Colorectal CancerSquamous Cell Carcinoma of the Head and NeckEpithelial Tumor
Akamis Bio 51
Testing effectiveness (Phase 2)Study completedNCT00446446
What this trial is testing

PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)

Who this might be right for
CancerCarcinomaHead and Neck Cancer+6 more
Amgen 52
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT00057850
What this trial is testing

BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 27
Early research (Phase 1)Ended earlyNCT02817113
What this trial is testing

Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
Orient Europharma Co., Ltd. 4
Early research (Phase 1)Study completedNCT03236935
What this trial is testing

Phase Ib of L-NMMA and Pembrolizumab

Who this might be right for
Non-Small Cell Lung CancerMalignant MelanomaHead and Neck Squamous Cell Carcinoma+3 more
The Methodist Hospital Research Institute 12
Testing effectiveness (Phase 2)Study completedNCT01256385
What this trial is testing

Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+33 more
National Cancer Institute (NCI) 86
Testing effectiveness (Phase 2)Study completedNCT05597839
What this trial is testing

Study of DF9001 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Dragonfly Therapeutics 24
Testing effectiveness (Phase 2)Study completedNCT00768664
What this trial is testing

Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Cancer

Who this might be right for
Head and Neck Neoplasms
Pfizer 69
Early research (Phase 1)Not Yet RecruitingNCT05582590
What this trial is testing

Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers

Who this might be right for
Oropharyngeal CancerHuman Papilloma VirusHead and Neck Cancer+8 more
NexImmune Inc. 36
Testing effectiveness (Phase 2)Ended earlyNCT00239200
What this trial is testing

Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus

Who this might be right for
Metastatic or Recurrent Squamous Cell Carcinoma of the Esophagus
University of Michigan Rogel Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT00095628
What this trial is testing

SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+19 more
National Cancer Institute (NCI) 21
Early research (Phase 1)Study completedNCT02110082
What this trial is testing

Combination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck Cancer

Who this might be right for
Colorectal CancerHead and Neck Cancer
Bristol-Myers Squibb 66
Testing effectiveness (Phase 2)Study completedNCT04732494
What this trial is testing

Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
BeiGene 125
Testing effectiveness (Phase 2)Ended earlyNCT03347123
What this trial is testing

Epacadostat and Nivolumab in Combination With Immune Therapies in Participants With Advanced or Metastatic Malignancies (ECHO-208)

Who this might be right for
Solid Tumors
Incyte Corporation 11
Testing effectiveness (Phase 2)Study completedNCT00030576
What this trial is testing

Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University Health Network, Toronto 51
Testing effectiveness (Phase 2)UnknownNCT00003326
What this trial is testing

Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Theradex 100
Early research (Phase 1)Study completedNCT01637194
What this trial is testing

Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer

Who this might be right for
Recurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Colon Cancer+46 more
Fox Chase Cancer Center 12
Next Page